错误 0001534675 DEF 14A 0001534675 2023-01-01 2023-12-31 0001534675 2022-01-01 2022-12-31 0001534675 2021-01-01 2021-12-31 iso4217:USD xbrli:股份 iso4217:USD xbrli:股份 xbrli:纯形

 

 

 

美国

证券交易委员会

华盛顿,特区。20549

 

时间表 14A

 

代理人 根据第14(a)条规定提交的声明

1934年《证券交易法》(修正案号)

 

由注册人☒提交

 

由注册人以外的当事人提交☐

 

勾选适当的选框:

 

初步代理声明书
机密,仅供委员会使用(根据规则14a-6(e)(2)允许)
最终代理声明书
最终补充资料
根据 § 240.14a-12号征求材料

 

TECNOGLASS INC.

仅限于其章程规定的注册人的名称

 

N/A

提交代理声明的人(如果不是注册人)

 

提交费用支付(勾选适当的选框):

 

无需费用。
   
以前用初步材料支付的费用。
   
根据Exchange Act规则14a6(i)(1)和0-11要求的展示表格计算的费用。

 

 

 

 

 

 

TECNOGLASS INC.

3550 西北49th

迈阿密,佛罗里达州33142

(57)(5) 3734000

 

2024年股东大会通知书

将于2024年12月3日举行

 

致Tecnoglass Inc.的股东:

 

诚挚邀请您参加2024年Tecnoglass Inc.年度股东大会(“年度股东大会”),将于2024年12月3日上午10:00在哥伦比亚巴兰基亚市Las Flores区Circunvalar大道距离Via 40大道100米处举行,届时请审议并投票以下事项:

 

  (1) 选举两名B类董事,任期为三年,直至选举并合格的继任者。

 

仅有在2024年11月5日业务结束时记录的股东有权收到通知,并在会议及其任何延期期间进行投票。

 

年度股东大会将以虚拟方式举行。 您可以通过访问https://www.cstproxy.com/tecnoglass/2024 或拨打以下号码(仅限听取)在线参加和参与年度股东大会。

 

美国和加拿大境内:1 800-450-7155(免费电话)

 

美国和加拿大以外:+1 857-999-9155(收取标准费率)

 

会议 ID: 3767178#

 

请查阅附带代理声明中的“问题和答案”以获取更多详细信息。

 

您被敦促阅读附上的代理声明,其中包含与会议上要采取的行动相关的信息。无论您是否打算出席会议,都请您日期、签名并退回所附的代理表格,放入附上地址的、预付邮资的信封中。退回代理不会影响您亲自出席会议时的投票权。如果您在投票前有任何意愿,可以随时撤销您的代理。我们将非常感激您迅速退回代理,这将有助于我们为会议做好准备。

 

  董事会令
   
  董事会主席A. Lorne Weil

 

佛罗里达州迈阿密

十一月 8, 2024

 

关于委托材料可用性的重要通知

2023年股东大会将于2024年12月3日举行

 

我们2024年的股东大会通函,日期为2024年11月8日,以及我们截至2023年12月31日的财年年度报告10-k表格,已于2024年2月29日向证券交易委员会(“SEC”)提交,可在https://investors.tecnoglass.com/financials/annual-reports/default.aspx上获取。

 

2

 

 

TECNOGLASS INC.

 

代理声明

2024年度股东大会

将于2024年12月3日举行

 

本次代理声明和随附的代理表,是为了向 Tecnoglass Inc. 的股东提供,在我们的2024年度股东大会("年度股东大会")上由我们的董事会发起的代理投票中使用,该会议将于2024年12月3日上午10:00在哥伦比亚巴兰基亚的Barrio Las Flores的Via 40大道100米以内的Avenida Circunvalar举行,以及任何和所有的休会后续开会。

 

此代理声明、附带的年度股东大会通知书、代理人和截至2023年12月31日的股东年度报告已经邮寄给2024年11月5日的股东记录。我们承担所有这次征求意见的费用。

 

问题与回答

 

我将投票选择什么?

 

您被要求投票选举两名乙类董事,任期为三年,直至选出并合格的继任者。

 

董事会有什么建议?

 

我们的董事会建议您投票:

 

✔ 选择此代理声明中提名的董事候选人。

 

谁有投票权?

 

2024年11月5日业务结束时持有我们普通股的股东,即记录日,有权在会议上投票。截至记录日,我们已发行和流通的普通股为46,995,298股,是我们唯一流通的投票证券类别。截至记录日,每位普通股股东有权投一票。

 

如何进行投票?

 

如果您是股份的持有人,您可以通过以下方式在年度股东大会上投票您的普通股:

 

  通过邮件您可以通过签署并退回附有的代理人卡进行代理投票,下文将更详细讨论;或
     
  通过参加年度股东大会您可以参加年度股东大会,并通过年度股东大会网络直播投票。

 

如果 您持有的股份以经纪人、银行或其他代理人的名义持有,您应该联系您的经纪人、银行或其他代理人,确保与您所拥有的股份相关的投票被正确计算。

 

我如何参加2024年年度股东大会?

 

年度股东大会将以虚拟会议形式举行。任何希望参加年度股东大会的股东必须提前注册。 要注册并参加年度股东大会,请根据您拥有公司普通股的性质,按照以下指示操作:

 

记录股东如果您是记录所有者,希望参加年度股东大会,请访问 https://www.cstproxy.com/tecnoglass/2024,输入您在代理卡或会议通知上收到的控制号码, 并单击页面顶部的“单击此处预先注册在线会议”链接。 您需要在年度股东大会开始前立即使用您的控制号码 重新登录会议网站。 您必须在会议开始之前注册。 您也可以使用以下号码拨入会议(仅限听):

 

Within the U.S. and Canada: 1 800-450-7155 (toll-free)

 

Outside of the U.S. and Canada: +1 857-999-9155 (standard rates apply)

 

Conference ID: 3767178#

 

Beneficial Owners. Beneficial owners who wish to attend the Annual General Meeting must obtain a legal proxy from the shareholder of record and e-mail a copy of their legal proxy to proxy@continentalstock.com. Beneficial owners should contact their bank, broker, or other nominee for instructions regarding obtaining a legal proxy. Beneficial owners who e-mail a valid legal proxy will be issued a meeting control number that will allow them to register to attend and participate in the Annual General Meeting. You will receive an e-mail prior to the meeting with a link and instructions for entering the Annual General Meeting. Beneficial owners should contact Continental Stock Transfer on or before 5:00 p.m. Eastern Time on November 26, 2024.

 

What is the effect of giving a proxy?

 

Proxies in the form enclosed are solicited by and on behalf of our board of directors. The persons named in the proxy have been designated as proxies by our board of directors. If you sign and return the proxy in accordance with the procedures set forth in this proxy statement, the persons designated as proxies by our board of directors will vote your shares at the meeting as specified in your proxy.

 

3

 

 

If you sign and return your proxy in accordance with the procedures set forth in this proxy statement but you do not provide any instructions as to how your shares should be voted, your shares will be voted FOR the election of the Class B director nominees (Proposal 1).

 

If you give your proxy, your shares also will be voted in the discretion of the proxies named on the proxy card with respect to any other matters properly brought before the meeting and any adjournments. If any other matters are properly brought before the meeting, the persons named in the proxy will vote the proxies in accordance with their best judgment.

 

May I change my vote after I return my proxy card?

 

If you are a record owner of your shares and you give a proxy, you may revoke your proxy at any time before it is exercised by:

 

  sending another proxy card with a later date;
     
  notifying our corporate secretary in writing before the Annual General Meeting that you have revoked your proxy; or
     
  attending the Annual General Meeting webcast, revoking your proxy, and voting via the webcast.

 

Please note that your attendance at the virtual meeting will not alone serve to revoke your proxy.

 

If your shares are held in the name of your broker, bank or another nominee, you should contact your broker, bank or such other nominee for information on how to revoke your voting instructions.

 

What is a quorum?

 

A quorum is the minimum number of shares required to be present at the Annual General Meeting for the meeting to be properly held under our Third Amended and Restated Memorandum and Articles of Association. The presence, in person, by proxy or, if a corporation or other non-natural person, by its duly authorized representative or proxy, of the holders of a majority of our ordinary shares constitutes a quorum. Proxies that are marked “abstain” and proxies relating to “street name” shares that are returned to us but marked by brokers as “not voted” will be treated as shares present for purposes of determining the presence of a quorum on all matters. The latter will not be treated as shares voting on the matter as to which authority to vote is withheld from the broker. If a shareholder does not give the broker voting instructions, under applicable self-regulatory organization rules, its broker may not vote its shares on “non-routine” proposals, such as the election of Class B directors.

 

How many votes are needed for approval of the proposals?

 

Election of directors. Directors are elected by ordinary resolution under Cayman Islands law which will require the affirmative vote of the holders of a majority of ordinary shares present (in person or by proxy or, if a corporation or other non-natural person, by its duly authorized representative) who, being entitled to vote on such proposal at the Annual General Meeting, attend and vote. Abstentions and broker non-votes, while considered present for the purposes of establishing a quorum, will have no effect on such proposal.

 

If you hold your shares through a broker, bank, or other financial institution, your broker will not be permitted to vote on your behalf on any of the proposals set forth in this proxy statement, without your instructions to do so. Please communicate your voting instructions to your broker, bank, or other financial institution before the meeting so that your vote will be counted.

 

4

 

 

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

 

The table and accompanying footnotes set forth certain information based on public filings or information known to Tecnoglass as of November 5, 2024 with respect to the ownership of our ordinary shares by:

 

  each person or group who beneficially owns more than 5% of our ordinary shares;
     
  each of our executive officers and directors; and
     
  all of our directors and executive officers as a group.

 

A person is deemed to be the “beneficial owner” of a security if that person has or shares “voting power,” which includes the power to vote or to direct the voting of such security, or “investment power,” which includes the power to dispose of or to direct the disposition of such security.

 

Name and Address of Beneficial Owner(1)  Amount and
Nature of Beneficial
Ownership
   Approximate
Percentage of
Beneficial
Ownership
 
Directors and Named Executive Officers          

Jose M. Daes

Chief Executive Officer and Director

   0(2)   0%

Christian T. Daes

Chief Operating Officer and Director

   0(2)   0%

Carlos Cure

Director

   0    0%

Luis F. Castro

Director

   0    0%

Santiago Giraldo

Chief Financial Officer

   0    0%

A. Lorne Weil

Chairman of the Board

   88,173(3)   *  

Julio A. Torres

Director

   30,520    *  

Anne Louise Carricarte

Director

   0    0%
All current directors and executive officers as a group (8 persons)   118,693    * 
Five Percent Holders:          
ENERGY HOLDING CORPORATION   24,628,108(4)   52.4%
FMR LLC   2,613,856(5)   5.6%

 

* Less than 1%

 

(1) Unless otherwise indicated, the business address of each of the individuals is c/o Tecnoglass Inc., 3550 NW 49th Street, Miami, Florida 33142.
   
(2) Does not include shares held by ENERGY HOLDING CORPORATION, in which this person has an indirect ownership interest.
   
(3) Does not include 140,031 ordinary shares held by Child’s Trust f/b/o Francesca Weil u/a dated March 4, 2010 and 140,031 ordinary shares held by Child’s Trust f/b/o Alexander Weil u/a dated March 4, 2010, irrevocable trusts established for the benefit of Mr. Weil’s children.
   
(4) Joaquin Fernandez and Alberto Velilla Becerra are the directors of ENERGY HOLDING CORPORATION and may be deemed to share voting and dispositive power over such shares.
   
(5) The business address of FMR LLC is 245 Summer Street, Boston, Massachusetts 02210. Based on information contained in a Schedule 13G filed by FMR LLC on February 9, 2024.

 

5

 

 

PROPOSAL 1 – ELECTION OF CLASS B DIRECTORS

 

Our board of directors is divided into three classes with only one class of directors being elected in each year and each class serving a three-year term. The term of office of our Class B directors, consisting of Christian T. Daes and Julio A. Torres, will expire at this year’s annual general meeting. The term of office of our Class C directors, consisting of Jose M. Daes and A. Lorne Weil, will expire at our annual general meeting in 2025. The term of office of our Class A directors, consisting of Anne Louise Carricarte, Luis Fernando Castro and Carlos Cure, will expire at our annual general meeting in 2026.

 

Our nominating committee has nominated each of Christian T. Daes and Julio A. Torres to be re-elected as a Class B director.

 

At the Annual General Meeting, shareholders will vote on the following resolution:

 

RESOLVED, as an ordinary resolution, that each of Christian T. Daes and Julio A. Torres be re-appointed as a Class B director to hold office in accordance with the third amended and restated memorandum and articles of association of the Company noting that they had accepted their respective appointments on the basis that the indemnity in the third amended and restated memorandum and articles of association of the Company would be deemed to form part of their service contract and/or terms of appointment with the Company and, accordingly, that they would be able to enforce such indemnity, if necessary, against the Company.

 

Recommendation and Vote Required

 

Election of directors. Directors are elected by ordinary resolution under Cayman Islands law which will require the affirmative vote of the holders of a majority of the ordinary shares present (in person or by proxy or, if a corporation or other non-natural person, by its duly authorized representative) who, being entitled to vote on such proposal at the Annual General Meeting, attend and vote. Abstentions and broker non-votes, while considered present for the purposes of establishing a quorum, will have no effect on such proposal.

 

Unless authority is withheld or the shares are subject to a broker non-vote, the proxies solicited by the board of directors will be voted “FOR” the election of these nominees. In case any of the nominees becomes unavailable for election to the board of directors, an event that is not anticipated, the persons named as proxies, or their substitutes, will have full discretion and authority to vote or refrain from voting for any other candidate in accordance with their judgment.

 

THE COMPANY’S BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT YOU VOTE “FOR” EACH OF THE CLASS B DIRECTOR NOMINEES LISTED IN THIS PROXY STATEMENT.

 

Information About Directors, Nominees, Executive Officers and Significant Employees

 

Our current directors and executive officers are as follows:

 

Name   Age   Position
José M. Daes   65   Chief Executive Officer and Director
Christian T. Daes   61   Chief Operating Officer and Director
Santiago Giraldo   49   Chief Financial Officer
A. Lorne Weil   78   Non-Executive Chairman of the Board
Luis Fernando Castro Vergara   58   Director
Anne Louise Carricarte   58   Director
Julio A. Torres   58   Director
Carlos Alfredo Cure Cure   80   Director

 

José M. Daes has served as our chief executive officer and a director since December 2013. Mr. Daes has over 40 years’ experience starting and operating various businesses in Colombia and the United States. Since 1983, he has led the Tecnoglass group, founded with his brother Christian Daes, our chief operating officer and a director. Mr. Daes has served as chief executive officer of C.I. Energia Solar S.A. E.S. Windows (“ES”) since its inception, responsible for all aspects of ES’s operations. Mr. Daes also co-founded Tecnoglass S.A. (“TG”). Mr. Daes is responsible for the continuous, ethical and responsible management and growth of our company.

 

We believe Mr. Daes is well-qualified to serve as a member of our board of directors due to his operational experience with ES and TG, our operating subsidiaries, and his knowledge of the industry within which they operate.

 

Christian T. Daes has served as our chief operating officer and a director since December 2013. Mr. Daes has served as the chief executive officer of TG since its inception in 1994. Mr. Daes leads the automation projects, which reduce the consumption of materials and increase the efficiency of our company, maintaining the highest safety standards for our workers and the entire international supply chain. Mr. Daes is the younger brother of Jose M. Daes, our Chief Executive Officer and a director.

 

6

 

 

We believe Mr. Daes is well-qualified to serve as a member of our board of directors due to his operational experience with ES and TG and his knowledge of the industry within which they operate.

 

Santiago Giraldo served as our deputy chief financial officer from February 2016 until August 2017 and has served as our chief financial officer since such time. He joined Tecnoglass with significant financial experience in capital markets, bank debt, derivatives, treasury, M&A and equity related transactions. Mr. Giraldo received a Business Administrator (cum laude) from Washburn University and holds an MBA with an emphasis in International Business and Finance from California State University at Pomona.

 

A. Lorne Weil has served as our Non-Executive Chairman of the board of directors since our inception in September 2011. Mr. Weil is the Executive Chairman of Inspired Entertainment, Inc. and was the co-sponsor and founder of lnspired’s predecessor, Hydra Industries Acquisition Corp., and previously served as its Chairman and Chief Executive Officer from 2014 to December 2016. Mr. Weil has been a principal of Hydra Management, an investment vehicle he formed, since September 2014. Mr. Weil was also the Chairman of the Board of Scientific Games Corporation from October 1991 to November 2013, and was its Chief Executive Officer from April 1992 to November 2013. During his tenure, Scientific Games grew from under $50 million in annualized revenue to approximately $2 billion. Mr. Weil received a Bachelor of Commerce from the University of Toronto, an M.S. from the London School of Economics and an M.B.A. from Columbia University.

 

We believe Mr. Weil is well-qualified to serve as a member of our board of directors due to his extensive business experience in strategic planning and corporate development, his contacts he has fostered throughout his career, as well as his operational experience.

 

Luis Fernando Castro Vergara has served on our board of directors since November 2018. Since 2017, Mr. Castro Vergara has been serving as a fund manager of a private equity fund in the agroindustry sector and overseeing his investments in the construction, infrastructure and agroindustry sectors. Mr. Castro Vergara served as the Chief Executive Officer of Banco de Comercio Exterior de Colombia S.A., Colombia’s development bank, from 2013 to 2017. From 2007 to 2008 and 2012 to 2013, Mr. Castro Vergara was the General Manager of Agrodex International SAS, an import and marketing food company. From 2008 to 2012, he was the Regional Development Agency President of the Barranquilla Chamber of Commerce. Previously, he was General Manager of Provyser S.A., a commercialization and logistics services company in the food industry. He is on the board of directors of Unimed Pharmaceuticals Limited, where he also serves as member of the audit committee, and of Colombian companies Accenorte SAS and Devimed SAS. Mr. Castro Vergara received a B.S. from Fordham University, a B.S. from Columbia University and a M.B.A. from the Universidad de los Andes Bogota in Colombia.

 

We believe Mr. Castro Vergara is well-qualified to serve as a member of our board of directors due to his contacts and business relationships and experience as an independent member on other boards.

 

Anne Louise Carricarte has served on our board of directors since August 2022. Ms. Carricarte has over 35 years of experience in domestic and international marketing, sales, administration, and management. She is a business entrepreneur, executive consultant, and inspirational speaker skilled in motivation, training, negotiation, and in-depth team building. Ms. Carricarte is the Chief Executive Officer of Simple Results, Inc., a consulting company she founded in 2006, where she collaborates on multi-cultural projects between countries, generations, professions, and faiths in both the private and public sectors. Since 2004, Ms. Carricarte has served as an advisor to Grove Services, a farm-land asset management company, and Unity Groves, which provides ‘end-to-end’ produce distribution to major US food chains. She is also one of seven board members for Mathon Investments Corporation, a private fund that manages investments and provides lending services. From 1992 until she founded Simple Results, Ms. Carricarte was the Chief Operating Officer of Amedex Holding Insurance Companies/USA Medical and Chief Executive Officer of Amedex International, which provided health and life insurance products and related services to clients in Latin America and the Caribbean.

 

We believe Ms. Carricarte is well-qualified to serve as a member of our board of directors due to her contacts and business relationships.

 

7

 

 

Julio A. Torres has served on our board of directors since October 2011. He previously served as our co-Chief Executive Officer from October 2011 through January 2013. Since March 2008, Mr. Torres has served as Managing Director of Nexus Capital Partners, a private equity firm. From April 2006 to February 2008, Mr. Torres served with the Colombian Ministry of Finance acting as the general director of public credit and the treasury. From June 2002 to April 2006, Mr. Torres served as Managing Director of Diligo Advisory Group, an investment banking firm. From September 1994 to June 2002, Mr. Torres served as Vice President with JPMorgan Chase Bank. Mr. Torres has served on the board of directors of AST SpaceMobile, Inc., a company building the first space-based cellular broadband network accessible directly by standard mobile phones, since April 2021. Mr. Torres received a degree in systems and computer engineering from Los Andes University, an M.B.A. from Northwestern University and a M.P.A. from Harvard University.

 

We believe Mr. Torres is well-qualified to serve as a member of our board of directors due to his operational experience with Nexus Capital Partners, his work with the Colombian government and his extensive contacts he has fostered while working at Nexus Capital Partners, JPMorgan Chase Bank and in the Colombian government.

 

Carlos Alfredo Cure Cure has served on our board of directors since September 2019. Mr. Cure Cure currently acts as external advisor to Grupo Olímpica, one of the largest multi-industry conglomerates in Colombia, and was the former Chairman of the board of directors of Ecopetrol S.A., the leading oil & gas company in Colombia, from September 2015 to March 2019. From 2011 to 2013, Mr. Cure Cure served as the Colombian Ambassador to Venezuela. Earlier in his carrier, Mr. Cure Cure was the Financial Manager of Cementos del Caribe, General Manager of Cementos Toluviejo, General Manager of Astilleros Unión Industrial, and Sociedad Portuaria de Barranquilla. Mr. Cure Cure has served as a board member of Avianca and Isagen, and is the former President of Bavaria S.A. Mr. Cure Cure earned a B.S. in Civil Engineering from Universidad Nacional de Colombia.

 

We believe Mr. Cure Cure is well-qualified to serve as a member of our board of directors due to his leadership experience in other boards, contacts and business relationships in Colombia.

 

Director Independence

 

Our ordinary shares are listed on the New York Stock Exchange (“NYSE”) and therefore, we adhere to the NYSE listing standards in determining whether a director is independent. Our board of directors consults with its counsel to ensure that the board’s determinations are consistent with those rules and all relevant securities and other laws and regulations regarding the independence of directors.

 

The NYSE listing standards define an “independent director” as a person, other than an executive officer of a company or any other individual having a relationship which, in the opinion of the issuer’s board of directors, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. Consistent with these considerations, we have affirmatively determined that Messrs. Weil, Cure, Castro Vergara, Torres and Ms. Carricarte qualify as independent directors. Our independent directors have regularly scheduled meetings at which only independent directors are present.

 

8

 

 

Board of Directors Meetings and Committees

 

Our board of directors held four (4) meetings in 2023 and acted by written consent four (4) times. We held our 2023 annual general meeting on December 28, 2023, which was attended by all of our directors. No director attended fewer than 75% of the meetings of the board and of the committees thereof upon which he or she served in 2023.

 

We do not have any formal policy regarding director attendance at annual general meetings of shareholders; however, we attempt to schedule our annual general meetings so that all of our directors can attend. In addition, we expect our directors to attend all board and committee meetings and to spend the time needed and meet as frequently as necessary to properly discharge their responsibilities.

 

Leadership Structure

 

Our board of directors has determined to keep separate the positions of board chairman and chief executive officer at this time. This permits our chief executive officer to concentrate his efforts primarily on managing the Company’s business operations and development, while our chairman can focus on, among other things, communications and relations between our board of directors and senior management, consideration by our board of directors of the Company’s strategies and policies and our chief executive officer evaluation processes.

 

Risk Oversight

 

Our board of directors’ primary function is one of oversight. Our board of directors as a whole has responsibility for risk oversight and reviews management’s risk assessment and risk management policies and procedures. Our audit committee discusses with our management major financial risk exposures and reports its findings to our board of directors in connection with our board of directors’ risk oversight review. Our compensation committee is responsible for creating incentives that encourage behavior consistent with our business strategy, without encouraging undue risk-taking.

 

We believe our leadership structure is appropriate for the Company because it ensures accountability for oversight of particular kinds of risks reasonably expected to be faced by the Company is based on the expertise and qualifications of the person(s), in such position(s) and/or on such committee(s), as are primarily responsible for oversight and management of such particular risks. We also, as described elsewhere herein, make efforts to attract and retain the highest quality and most diverse directors. By ensuring that particularly qualified persons are in the position(s) to oversee, mitigate and otherwise manage each particular kind of risk reasonably expected to be faced by the Company, our leadership structure is appropriate to manage risk oversight by the Company.

 

Code of Conduct

 

In October 2017, we adopted an updated code of conduct that applies to all of our executive officers, directors and employees. The code of conduct codifies the business and ethical principles that govern all aspects of our business. We will provide, without charge, upon request, copies of our code of conduct. Requests for copies of our code of conduct should be sent in writing to Tecnoglass Inc., 3550 NW 49th Street, Miami, Florida 33142, Attn: Corporate Secretary. Readers can also obtain a copy of our code of conduct on our website at https://investors.tecnoglass.com/governance/governance-overivew/default.aspx.

 

Corporate Governance

 

Audit Committee

 

We have an audit committee of the board of directors, which consists of Carlos A. Cure, Luis Fernando Castro and Julio Torres, with Mr. Cure serving as chairman. Each of the members of the audit committee is independent under the applicable NYSE listing standards.

 

The audit committee held four (4) meetings and acted by written consent on one (1) occasion in 2023. The audit committee has a written charter, which is included in our compendium of Corporate Governance Guidelines and can be found on our website at https://investors.tecnoglass.com/governance/governance-overivew/default.aspx. The purpose of the audit committee is to assist the Board in monitoring the integrity of the annual, quarterly and other financial statements of the Company, the independent auditor’s qualifications and independence, the performance of the Company’s independent auditor and the compliance by the Company with legal and regulatory requirements. appoint, retain, set compensation of, and supervise our independent accountants, review the results and scope of the audit and other accounting related services and review our accounting practices and systems of internal accounting and disclosure controls. The audit committee’s duties, which are specified in the audit committee charter, include, but are not limited to:

 

  Meet with the independent auditor prior to the audit to review the scope, planning and staffing of the audit.

 

9

 

 

  Review and discuss with management and the independent auditor the annual audited financial statements, and recommend to the Board whether the audited financial statements should be included in the Company’s Annual Report on Form 10-K (or the annual report to shareholders if distributed prior to the filing of the Form 10-K).
     
  Review and discuss with management and the independent auditor the Company’s quarterly financial statements prior to the filing of its Form 10-Q, including the results of the independent auditor’s review of the quarterly financial statements.
     
  Discuss with management and the independent auditor, as appropriate, significant financial reporting issues and judgments made in connection with the preparation of the Company’s financial statements, including:

 

  any significant changes in the Company’s selection or application of accounting principles;
     
  the Company’s critical accounting policies and practices;
     
  all alternative treatments of financial information within GAAP that have been discussed with management and the ramifications of the use of such alternative accounting principles;
     
  any major issues as to the adequacy of the Company’s internal controls and any special steps adopted in light of material control deficiencies; and
     
  any material written communications between the independent auditor and management, such as any management letter or schedule of unadjusted differences.

 

  Discuss with management the Company’s earnings press releases generally, including the use of “pro forma” or “adjusted” non-GAAP information, and any financial information and earnings guidance provided to analysts and rating agencies. Such discussion may be general and include the types of information to be disclosed and the types of presentations to be made.
     
  Discuss with management and the independent auditor the effect on the Company’s financial statements of (i) regulatory and accounting initiatives and (ii) off-balance sheet structures.
     
  Discuss with management the Company’s major financial risk exposures and the steps management has taken to monitor and control such exposures, including the Company’s risk assessment and risk management policies.
     
  Discuss with the independent auditor the matters required to be discussed by Statement on Auditing Standards No. 61 relating to the conduct of the audit, including any difficulties encountered in the course of the audit work, any restrictions on the scope of activities or access to requested information, and any significant disagreements with management.
     
  Review disclosures made to the Audit Committee by the Company’s Chief Executive Officer and Chief Financial Officer (or individuals performing similar functions) during their certification process for the Form 10-K and Form 10-Qs about any significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting and any fraud involving management or other employees who have a significant role in the Company’s internal control over financial reporting.
     
  At least annually, obtain and review a report from the independent auditor, consistent with the rules of the Public Company Accounting Oversight Board, regarding (a) the independent auditor’s internal quality-control procedures, (b) any material issues raised by the most recent internal quality-control review, or peer review, of the firm, or by any inquiry or investigation by governmental or professional authorities within the preceding five years respecting one or more independent audits carried out by the firm, (c) any steps taken to deal with any such issues and (d) all relationships between the independent auditor and the Company. Evaluate the qualifications, performance and independence of the independent auditor, including whether the auditor’s quality controls are adequate and the provision of permitted non-audit services is compatible with maintaining the auditor’s independence, and taking into account the opinions of management and the internal auditor. The Audit Committee shall present its conclusions with respect to the independent auditor to the Board.
     
  Verify the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law. Consider whether, in order to assure continuing auditor independence, it is appropriate to adopt a policy of rotating the independent auditing firm on a regular basis.

 

10

 

 

  Oversee the Company’s hiring of employees or former employees of the independent auditor who participated in any capacity in the audit of the Company.
     
  Be available to the independent auditor during the year for consultation purposes.
     
  Obtain assurance from the independent auditor that Section 10A(b) of the Exchange Act has not been implicated.
     
  Review and approve material or significant related-party transactions.
     
  Inquire and discuss with management the Company’s compliance with applicable laws and regulations and with the Company’s Code of Conduct and ethics and compliance program in effect at such time, if any, and, where applicable, recommend policies and procedures for future compliance.
     
  Review and approve procedures (which may be incorporated in the Company’s Code of Conduct, in effect at such time, if any) for the receipt, retention and treatment of complaints received by the Company regarding accounting, internal accounting controls or reports which raise material issues regarding the Company’s financial statements or accounting policies.
     
  Discuss with management and the independent auditor any correspondence with regulators or governmental agencies and any published reports that raise material issues regarding the Company’s financial statements or accounting policies.
     
  Discuss with the Company’s General Counsel legal matters that may have a material impact on the financial statements or the Company’s compliance policies.
     
  Review and approve material payments made to the Company’s officers and directors or its or their affiliates when not part of ordinary course of business. Any payments made to members of the Audit Committee will be reviewed and approved by the Board, with the interested director or directors abstaining from such review and approval.

 

Audit Committee Financial Expert

 

As required by the NYSE listing standards, the audit committee will at all times be composed exclusively of independent directors who are financially literate, as such qualification is interpreted by our board of directors in its business judgment. In addition, the committee has, and will continue to have, at least one member who has accounting or related financial management expertise, as interpreted by our board of directors in its business judgment. The board of directors has determined that Mr. Torres satisfies the NYSE’s requirements and also qualifies as an “audit committee financial expert” as defined under rules and regulations of the SEC.

 

Audit Committee Report

 

Our audit committee is responsible for supervising our independent accountants, reviewing the results and scope of the audit and other accounting related services and reviewing our accounting practices and systems of internal accounting and disclosure controls, among other things. These responsibilities include reviewing and discussing with management and the independent auditor the annual audited financial statements. The audit committee does not itself prepare financial statements or perform audits, and its members are not auditors or certifiers of our financial statements.

 

In fulfilling its oversight responsibility of appointing and reviewing the services performed by our independent registered public accounting firm, the audit committee carefully reviews the policies and procedures for the engagement of the independent registered public accounting firm, including the scope of the audit, audit fees, auditor independence matters and the extent to which the independent registered public accounting firm may be retained to perform non-audit related services.

 

The audit committee has reviewed and discussed the audited financial statements for the year ended December 31, 2023, with our management and PricewaterhouseCoopers Ltda. (“PwC”), our independent registered public accounting firm. The audit committee has also discussed with PwC the matters required to be discussed by the Statement on Auditing Standards No. 61, as amended (AICPA, Professional Standards, Vol. 1, AU Section 380), as adopted by the Public Company Accounting Oversight Board (United States) in Rule 3200T regarding “Communication with Audit Committees.”

 

11

 

 

The audit committee has also received and reviewed the written disclosures and the letter from PwC required by applicable requirements of the Public Company Accounting Oversight Board regarding PwC’s communications with the audit committee concerning independence, and has discussed with PwC its independence from the Company.

 

Based on the reviews and discussions referred to above, the audit committee recommended to the board that the financial statements referred to above be included in our annual report on Form 10-K for the year ended December 31, 2023.

 

  MEMBERS OF THE AUDIT COMMITTEE
   
  Carlos A. Cure (Chairperson)
  Luis Fernando Castro
  Julio A. Torres

 

Nominating Committee

 

We have a nominating committee, which consists of A. Lorne Weil and Anne Louise Carricarte, with A. Lorne Weil serving as chairperson. Each member of the nominating committee is an “independent director” as defined under NYSE listing standards. Pursuant to its written charter, which is included in our compendium of Corporate Governance Guidelines and can be found on our website at https://investors.tecnoglass.com/governance/governance-overivew/default.aspx, our nominating committee is responsible for overseeing the selection of persons to be nominated to serve on our board of directors. The nominating committee met two (2) times in 2023.

 

Guidelines for Selecting Director Nominees

 

The nominating committee considers persons identified by its members, management, shareholders, investment bankers and others. Candidates will be reviewed in the context of current composition of the board of directors (including the diversity in background, experience, and viewpoints of the board), the operating requirements of the Company and the long-term interests of the Shareholders. Currently, the guidelines for selecting nominees, which are specified in the nominating committee charter, generally provide that persons to be nominated:

 

  should have demonstrated notable or significant achievements in business, education or public service;
     
  should possess the requisite intelligence, education and experience to make a significant contribution to the board of directors and bring a range of skills, diverse perspectives and backgrounds to its deliberations; and
     
  should have the highest ethical standards, a strong sense of professionalism and intense dedication to serving the interests of the shareholders.

 

The nominating committee will consider a number of qualifications relating to management and leadership experience, background and integrity and professionalism in evaluating a person’s candidacy for membership on the board of directors. The nominating committee may require certain skills or attributes, such as financial or accounting experience, to meet specific board needs that arise from time to time and will also consider the overall experience and makeup of its members to obtain a broad and diverse mix of board members. The nominating committee does not distinguish among nominees recommended by shareholders and other persons.

 

Compensation Committee

 

In December 2013, we established a compensation committee. Our compensation committee currently consists of Julio Torres and Luis Fernando Castro Vergara, with Julio Torres serving as chairperson. Each member of the compensation committee is an “independent director” as defined under NYSE listing standards. The compensation committee met two (2) times in 2023. The compensation committee’s duties, which are specified in our compensation committee charter included in our compendium of Corporate Governance Guidelines and can be found on our website at https://investors.tecnoglass.com/governance/governance-overivew/default.aspx, include, but are not limited to:

 

  Establish, review and approve the overall executive compensation philosophy and policies of the Company, including the establishment, if deemed appropriate, of performance-based incentives that support and reinforce the Company’s long-term strategic goals, organizational objectives and stockholder interests.

 

12

 

 

  Review and approve the Company’s goals and objectives relevant to the compensation of the CEO, annually evaluate the CEO’s performance in light of those goals and objectives, determine the CEO’s compensation level, including, but not limited to, salary, bonus or bonus target levels, long and short-term incentive and equity compensation, retirement plans, and deferred compensation plans as the compensation committee deems appropriate. In determining the long-term incentive component of the CEO’s compensation, the compensation committee is required to consider, among other factors, the Company’s performance and relative stockholder return, the value of similar incentive awards to CEO’s at comparable companies, and the awards given to the Company’s CEO in past years. The CEO shall not be present during voting and deliberations relating to CEO compensation.
     
  Determine the compensation of all other executive officers, including, but not limited to, salary, bonus or bonus target levels, long and short-term incentive and equity compensation, retirement plans, and deferred compensation plans, as the compensation committee deems appropriate. Members of senior management may report on the performance of the other executive officers of the Company and make compensation recommendations to the compensation committee, and the compensation committee will review and, as appropriate, approve the compensation recommendations.
     
  Administer or delegate the power to administer the Company’s incentive and equity-based compensation plans, including the grant of stock options, restricted stock and other equity awards under such plans.
     
  Review and make recommendations to the Board with respect to the adoption of, and amendments to, incentive compensation and equity-based plans and approve for submission to the stockholders all new equity compensation plans that must be approved by stockholders pursuant to applicable law.
     
  Review and approve for the CEO and the other executive officers of the Company any employment agreements, severance arrangements, and change in control agreements or provisions.
     
  Review and discuss with the Company’s management the Compensation Discussion and Analysis set forth in SEC Regulation S-K, Item 402, if required, and, based on such review and discussion, determine whether to recommend to the Board of Directors of the Company that the Compensation Discussion and Analysis be included in the Company’s annual report or proxy statement for the annual meeting of stockholders.
     
  Provide, over the names of the members of the compensation committee, the Compensation Committee Report for the Company’s annual report or proxy statement for the annual meeting of stockholders, if required.
     
  Conduct an annual performance evaluation of the compensation committee. In conducting such review, the committee is required to evaluate and address all matters that the committee considers relevant to its performance, including at least the following: (a) the adequacy, appropriateness and quality of the information received from management or others; (b) the manner in which the committee’s recommendations were discussed or debated; (c) whether the number and length of meetings of the committee were adequate for the committee to complete its work in a thorough and thoughtful manner; and (d) whether the charter of the compensation committee appropriately addresses the matters that are or should be within its scope.
     
  The compensation committee has the authority, to the extent it deems appropriate, to conduct or authorize investigations into or studies of matters within the compensation committee’s scope of responsibilities and to retain one or more compensation consultants to assist in the evaluation of CEO or executive compensation or other matters. The compensation committee has the sole authority to retain and terminate any such consulting firm, and to approve the firm’s fees and other retention terms. The compensation committee is required to evaluate whether any compensation consultant retained or to be retained by it has any conflict of interest in accordance with Item 407(e)(3)(iv) of Regulation S-K. The compensation committee also has the authority, to the extent it deems necessary or appropriate, to retain legal counsel or other advisors. In retaining compensation consultants, outside counsel and other advisors, the compensation committee must take into consideration factors specified in the NYSE listing rules. The Company will provide for appropriate funding, as determined by the compensation committee, for payment of any such investigations or studies and the compensation to any consulting firm, legal counsel or other advisors retained by the compensation committee.

 

13

 

 

EXECUTIVE OFFICER AND DIRECTOR COMPENSATION

 

Overview

 

Compensation Philosophy

 

Our policies with respect to the compensation of our executive officers and directors are administered by our board in consultation with our compensation committee. Our compensation policies are intended to provide for compensation that:

 

● is sufficient to attract and retain executives and directors of outstanding ability and potential;

 

● is tailored to the unique characteristics and needs of our company;

 

● considers individual value and contribution to our success;

 

● is designed to motivate our executive officers to achieve our annual and long-term goals by rewarding performance based on the attainment of those goals;

 

● is designed to appropriately take into account risk and reward in the context of our business environment;

 

● reflects an appropriate relationship between executive compensation and the creation of shareholder value; and

 

● is sensitive to market benchmarks.

 

The compensation committee is charged with recommending executive compensation packages to our board that meet these goals. In making decisions about executive compensation, the compensation committee relies on the experience of its members as well as subjective considerations of various factors, including individual and corporate performance, our strategic business goals, each executive’s position, experience, level of responsibility, and future potential, and compensation paid by companies of similar size in our industry. The compensation committee does not set specific targets or benchmarks for overall compensation or for allocations between different elements of compensation, nor does the committee utilize any fixed formula in respect of such allocations.

 

Our compensation committee is charged with performing an annual review of our executive officers’ cash compensation and equity holdings to determine whether they provide adequate incentives and motivation to executive officers and whether they adequately compensate the executive officers relative to comparable officers in other companies. As part of this review, management submits recommendations to the compensation committee.

 

We believe it is important when making compensation-related decisions to be informed as to current practices of similarly situated publicly held companies in our industry. Our compensation committee stays appraised of the cash and equity compensation practices of publicly held companies in the glass and aluminum industries through the review of such companies’ public reports and through other resources. The companies chosen for inclusion in any benchmarking group would have business characteristics comparable to our company, including revenues, financial growth metrics, stage of development, employee headcount and market capitalization. While benchmarking may not always be appropriate as a stand-alone tool for setting compensation due to the aspects of our business and objectives, we generally believe that gathering this information is an important part of our compensation-related decision-making process.

 

We also take into consideration our most recent shareholder advisory vote on executive compensation, as required by Section 14A of the Securities Exchange Act of 1934. In the last advisory vote, conducted at our annual general meeting on December 15, 2022, our compensation program was approved on an advisory basis by over 99% of the shareholders who submitted a vote thereabout (with less than 1% of the votes being against approval or abstaining, collectively). We consider this to be a strong validation that our pay practices are firmly aligned with our shareholders’ best interests.

 

At present, the only elements of compensation paid to our executive officers are base salaries paid in cash, annual performance bonuses also paid in cash, and certain other benefits, each as further described below.

 

Base Salaries

 

Each of our named executive officers is employed on an at-will basis. We do not have employment agreements in place for our named executive officers. Base salaries for our executive officers are individually determined by our compensation committee each year to ensure that each executive’s base salary forms part of a compensation package which appropriately rewards the executive for the value he or she brings to our company and thereby our shareholders. In accordance with our compensation philosophy, salaries are chosen to reflect respective executives’ level of responsibility and experience, the scope and complexity of their position, and market data. Each executive’s base salary may be increased or decreased in the discretion of the compensation committee in accordance with our compensation philosophy.

 

14

 

 

Bonuses

 

In addition to their base salaries, our named executive officers are entitled to receive annual performance bonuses based on the company’s financial performance and achievement of certain targets throughout the year. We believe this drives Company performance ultimately benefitting our shareholders, as payout is based upon performance against pre-established, realistic goals in line with our corporate strategy, chosen by our compensation committee specifically to drive economic profit and shareholder value in both the short- and long-term.

 

Other Compensation and Benefits

 

Named executive officers receive additional compensation in the form of vacation, medical, 401(k), and other benefits generally available to all of our employees. We believe that including health- and wellbeing-focused elements such as these in our overall compensation mix helps ensure that our personnel are operating at peak effectiveness and thereby best able to drive shareholder value in line with our corporate strategy. We do not provide any other perquisites or other personal benefits to our named executive officers.

 

Summary Compensation Table

 

The following table summarizes the total compensation for the years ended December 31, 2023, 2022 and 2021, of each of our named executive officers.

 

Name and principal position  Year   Salary   Bonus   Other   Total (1) 
Jose M. Daes (2)   2023   $2,940,000   $1,029,000   $-   $3,969,000 
Chief Executive Officer   2022   $2,100,000   $735,000   $-   $2,835,000 
    2021   $1,512,000   $453,600   $-   $1,965,600 
Christian T. Daes (3)   2023   $2,940,000   $1,029,000   $-   $3,969,000 
Chief Operating Officer   2022   $2,100,000   $735,000   $-   $2,835,000 
    2021   $1,512,000   $453,600   $-   $1,965,600 
Santiago Giraldo (4)   2023   $594,000   $207,900   $-   $801,900 
Chief Financial Officer   2022   $440,000   $154,000   $-   $594,000 
    2021   $189,162   $47,634   $-   $236,796 
Carlos Amin (5)   2023   $225,000   $-   $1,416,989   $1,641,989 
Vice President of Sales   2022   $200,000   $-   $955,307   $1,155,307 
    2021   $317,676   $-   $690,055   $1,007,731 
Samir Amin (6)   2023   $225,000   $-   $1,416,989   $1,641,989 
Vice President of Operations and Logistics   2022   $200,000   $-   $955,307   $1,155,307 
    2021   $165,000   $-   $690,055   $855,055 

 

(1) During the period covered by the table, we did not issue any stock awards, option awards, non-equity incentive plan compensation, or other compensation, nor did any of the named executive officers experience any change in pension value and nonqualified deferred compensation earnings.
   
(2) Mr. Daes also serves as chief executive officer of ES.
   
(3) Mr. Daes also serves as chief executive officer of TG.
   
(4) Mr. Giraldo’s 2021 salary was paid in Colombian pesos.
   
(5) Mr. Amin serves as vice president of sales.
   
(6) Mr. Amin serves as vice president of operations and logistics.

 

PAY VERSUS PERFORMANCE ANALYSIS

 

Year  Summary Compensation Table Total for PEO ($)(1)   Compensation Actually Paid to PEO ($)(1)   Summary Compensation Table Total for Non-PEO NEOs ($) (2)   Compensation Actually Paid to Non-PEO NEOs ($)(2)*   On Total Shareholder Return ($)   Peer Group Total Shareholder Return   Net Income ($)   Operating Income 
           Average   Average   Value of Initial Fixed $100 Investment Based On:         
Year  Summary Compensation Table Total for PEO ($)(1)   Compensation Actually Paid to PEO ($)(1)   Summary Compensation Table Total for Non-PEO NEOs ($) (2)   Compensation Actually Paid to Non-PEO NEOs ($)(2)*   On Total Shareholder Return ($)   Peer Group Total Shareholder Return   Net Income ($)   Operating Income 
                                 
2023   3,969,000    3,969,000    2,385,450    2,385,450    712.03    68.51    183,000,000    259,804,000 
2022   2,835,000    2,835,000    1,714,500    1,714,500    475.00    104.65    156,412,000    226,415,000 
2021   1,965,600    1,965,600    1,101,198    1,101,198    399.35    148.82    68,428,000    116,985,000 

 

(1)For each of the years presented in the table, our principal executive officer (PEO) is our Chief Executive Officer, Jose M. Daes.
   
(2) For each of the years presented in the table, our non-principal executive officers (non-PEOs) are Christian T. Daes and Santiago Giraldo.

 

(2)For each of the years presented in the table, our non-principal executive officers (non-PEOs) are Christian T. Daes and Santiago Giraldo.

 

15

 

 

 

 

16

 

 

Compensation Arrangements with Named Executive Officers

 

On February 28, 2024, our compensation committee recommended, and on February 29, 2024 our Board approved, the following compensation arrangements for 2024 for each of Messrs. Daes, Daes, and Giraldo: (i) with respect to each of Messrs. Daes and Daes, a base salary of $3,292,800 plus a bonus of up to $1,152,480; and (ii) with respect to Mr. Giraldo, a base salary of $665,280 and a performance bonus of up to $232,848 per year. Each of the bonuses will be based on our 2023 financial performance and achievement of certain to-be-agreed upon targets throughout the year.

 

Pay Ratio Disclosures

 

The following pay ratio information is provided in accordance with the requirements of Item 402(u) of Regulation S-K of the Exchange Act.

 

For fiscal 2023, the Company’s last completed fiscal year:

 

  the median of the annual total compensation of all employees of the Company (other than the Chief Executive Officer) was $4,579; and
  the annual total compensation of the Company’s Chief Executive Officer, Jose M. Daes, was $3,969,000.

 

Based on this information, the ratio for 2023 of the annual total compensation of the Chief Executive Officer to the median of the annual total compensation of all employees is 868 to 1.

 

The following steps were taken to determine the annual total compensation of the median employee and the Chief Executive Officer:

 

  As of December 31, 2023, the employee population consisted of approximately 8,531 individuals, including full time, part time, temporary, and seasonal employees employed on that date. This date was selected because it aligned with calendar year end and allowed identification of employees in a reasonably efficient manner.
  For purposes of identifying the median employee from our employee population base, wages from our internal payroll records for the twelve-month period ended December 31, 2023, were used. These wages were consistent with amounts reported to taxation authorities for fiscal 2022. Consistent with the calculation of the Chief Executive Officer’s annual compensation, other elements of employee compensation were considered and added, if applicable when calculating the annual total compensation for all employees.
  In addition, the compensation of approximately 1,250 full time or part time employees who were hired during 2023 and employed on December 31, 2023, was annualized. No full-time equivalent adjustments were made for part time employees, of which there were approximately 172.
  The median employee was identified using this compensation measure and methodology, which was consistently applied to all employees. The amounts reported in the 2023 Summary Compensation Table for named executive officers was used for the total annual compensation of the Chief Executive Officer. The salary amount reported in this table was annualized to reflect a full year’s compensation for the purpose of calculating the pay ratio disclosure.

 

Potential Payments Upon Termination or Change-in-Control

 

As of December 31, 2023, none of our executive officers are entitled to payments or the provision of other benefits such as perquisites and health care benefits in connection with a termination or change-in-control.

 

17

 

 

Director Compensation

 

Each of our non-employee directors receives cash compensation of $63,063 each year. Additionally, our chairman of the Audit Committee and each other member of our Audit Committee receives additional cash compensation of $22,051 and $11,007, respectively, for serving on our Audit Committee. Non-employee directors do not receive cash compensation for their service.

 

The Company has not granted any stock awards, option awards, non-equity incentive plan compensation, or any other compensation to our directors, nor has any director experienced any change in pension value or nonqualified deferred compensation earnings.

 

The following table summarizes the compensation of our non-employee directors for the year ended December 31, 2023.

 

Name 

Fees earned or

paid in cash

  

Stock

Awards

   Total 
Carlos Cure  $128,180        -   $128,180 
Luis Fernando Castro Vergara  $113,539    -   $113,539 
Julio A. Torres  $100,838    -   $100,838 
A. Lorne Weil  $88,180    -   $88,180 
Anne Louise Carricarte  $113,539    -   $113,539 

 

To date, we have not compensated our directors with stock awards, option awards, non-equity incentive plan compensation, pension value, nonqualified deferred compensation earnings or other compensation.

 

Compensation Committee Interlocks and Insider Participation

 

No person who served as a member of the compensation committee of our board of directors during the last completed fiscal year, indicating each committee member (a) was, during the fiscal year, an officer or employee of ours; (b) was formerly an officer of the registrant; or (c) had any relationship requiring disclosure by us under any paragraph of Item 404 of Regulation S-K. We do not have any of the relationships described in Item 407(e)(4)(iii) that would require disclosure by us pursuant thereto.

 

Equity Compensation Plans

 

Category 

Number of securities to

be issued
upon exercise

of outstanding options,

warrants and rights

  

Weighted-average

exercise price of

outstanding options,

warrants and rights

  

Number of securities remaining

available for future issuance

under equity compensation plans

(excluding securities

reflected in

the first column)

 
Equity compensation plans approved by security holders           1,593,917(1)
Equity compensation plans not approved by security holders            
Total           1,593,917 

 

(1) On December 20, 2013, our shareholders approved our 2013 Long-Term Equity Incentive Plan. Under this plan, 1,593,917 ordinary shares are reserved for issuance in accordance with the plan’s terms to eligible employees, officers, directors and consultants. As of December 31, 2023, no awards had been made under the 2013 Plan.

 

18

 

 

Certain Relationships and Related-Party Transactions

 

Related Party Transactions

 

Alutrafic Led SAS

 

In the ordinary course of business, we sell products to Alutrafic Led SAS (“Alutrafic”), a fabricator of electrical lighting equipment. Affiliates of Jose Daes and Christian Daes, the Company’s Chief Executive Officer and Chief Operating Officer, respectively, have an ownership stake in Alutrafic. We sold $0.8 million to Alutrafic during fiscal year ended December 31, 2023. We had outstanding accounts receivable from Alutrafic for $0.3 million as of December 31, 2023.

 

Barranquilla Capital de Luz SAS

 

In the ordinary course of business, we purchase products from Barranquilla Capital de Luz SAS (“Alubaq”), a fabricator of electrical lighting equipment. Affiliates of Jose Daes and Christian Daes have an ownership stake in Alubaq. We purchased equipment from Alubaq for $0.4 million during the fiscal year ended December 31, 2023.

 

Fundacion Tecnoglass-ESWindows

 

Fundacion Tecnoglass-ESWindows is a non-profit organization set up by the Company to carry out social causes in the communities around where we operate. During the year ended December 31, 2023, we made charitable contributions of $3.3 million to the organization.

 

Il Vetro Ltd

 

In the ordinary course of business, we sell products to Il Vetro Ltd., a distributor and installer of architectural systems in the Bahamas that. is owned and controlled by family members of Giovanni Monti, who serves as a senior executive at our subsidiary GM&P. We sold $0.3 million to Il Vetro Ltd during fiscal year ended December 31, 2023.

 

19

 

 

Incantesimo SAS

 

On November 10, 2023, we acquired the remaining 30% equity interest in ESMetals previously not owned by us for an aggregate of $5.5 million from Incantesimo SAS, a Colombia domiciled company of which the primary beneficiary is Carlos Peña, who holds a senior management position at the Company. The Company paid $3.0 million during November and December 2023, and $2.5 million remains outstanding as of December 31, 2023, to be paid 6 months after the acquisition date.

 

Prisma-Glass LLC

 

In the ordinary course of business, we sell products to Prisma-Glass LLC, a distributor and installer of architectural systems in Florida that is owned and controlled by family members of Christian Daes. We sold $0.8 million to Prisma-Glass LLC during the fiscal year ended December 31, 2023 and had outstanding accounts receivable of $0.3 million as of December 31, 2023.

 

Santa Maria del Mar SAS

 

In the ordinary course of business, we purchase fuel for use at our manufacturing facilities from Estación Santa Maria del Mar SAS, a gas station located near our manufacturing campus which is owned by affiliates of Jose Daes and Christian Daes. During the year ended December 31, 2023, we purchased $1.3 million of fuel from this entity.

 

Studio Avanti SAS

 

In the ordinary course of business, we sell products to Studio Avanti SAS (“Avanti”), a distributor and installer of architectural systems in Colombia. Avanti is owned and controlled by Alberto Velilla, who is director of Energy Holding Corporation, the controlling shareholder of the Company. We sold $0.6 million to Avanti during the fiscal year ended December 31, 2023 and had outstanding accounts receivable from Avanti for $0.5 million as of December 31, 2023.

 

Vidrio Andino Joint Venture

 

On May 3, 2019, we consummated a joint venture agreement with Saint-Gobain, a world leader in the production of float glass, a key component of our manufacturing process, whereby we acquired a 25.8% minority ownership interest in Vidrio Andino, a Colombia-based subsidiary of Saint-Gobain. The purchase price for our interest in Vidrio Andino was $45 million, of which $34.1 million was paid in cash and $10.9 million paid through the contribution of land on December 9, 2020. On October 28, 2020, we acquired said land from a related party in exchange for an aggregate of 1,557,142 ordinary shares of the Company, valued at $7.00 per share, which represented an approximate 33% premium based on the closing stock price as of October 27, 2020.

 

The land will serve the purpose of developing a second float glass plant nearby our existing manufacturing facilities which we expect will carry significant efficiencies for us once it becomes operative, in which we will also have a 25.8% interest. The new plant will be funded with proceeds from the original cash contribution made by the Company, operating cashflows from the Bogota plant, debt incurred at the joint venture level that will not consolidate into the Company and an additional contribution by us of approximately $12.5 million if needed (based on debt availability as a first option).

 

In the ordinary course of business, we purchased $32.0 million from Vidrio Andino in 2023. As of December 31, 2023, we had outstanding payables to Vidrio Andino for $3.9 million. We recorded equity method income of $5.0 million on our Consolidated Statement of Operations during the year ended December 31, 2023. During the year ended December 31, 2023, we received a dividend payment of $2,282 from Vidrio Andino.

 

20

 

 

Zofracosta SA

 

We have an investment in Zofracosta SA, a real estate holding company located in the vicinity of the proposed glass plant being built through our Vidrio Andino joint venture, recorded at $0.8 million as of December 31, 2023. Affiliates of Jose Daes and Christian Daes have a majority ownership stake in Zofracosta SA.

 

Indemnification Agreements

 

We have entered into indemnification agreements with each of our executive officers and members of our board of directors. The indemnification agreements supplement our third amended and restated memorandum and articles of association and Cayman Islands law in providing certain indemnification rights to these individuals. The indemnification agreements provide, among other things that we will indemnify these individuals to the fullest extent permitted by Cayman Islands law and to any greater extent that Cayman Islands law may in the future permit, including the advancement of attorneys’ fees and other expenses incurred by such individuals in connection with any threatened, pending or completed action, suit or other proceeding, whether of a civil, criminal, administrative, regulatory, legislative or investigative nature, relating to any occurrence or event before or after the date of the indemnification agreements, by reason of the fact that such individuals is or were our directors or executive officers, subject to certain exclusions and procedures set forth in the indemnification agreements, including the absence of fraud or willful default on the part of the indemnitee and, with respect to any criminal proceeding, that the indemnitee had no reasonable cause to believe his conduct was unlawful.

 

Related Party Policy

 

Our Code of Conduct requires us to avoid, wherever possible, all related party transactions that could result in actual or potential conflicts of interests, except under guidelines approved by the board of directors (or the audit committee). Related-party transactions are defined as transactions in which (1) the aggregate amount involved will or may be expected to exceed $120,000 in any calendar year, (2) we or any of our subsidiaries are a participant, and (3) any (a) executive officer, director or nominee for election as a director, (b) greater than 5% beneficial owner of our ordinary shares, or (c) immediate family member, of the persons referred to in clauses (a) and (b), has or will have a direct or indirect material interest (other than solely as a result of being a director or a less than 10% beneficial owner of another entity). A conflict of interest situation can arise when a person takes actions or has interests that may make it difficult to perform his or her work objectively and effectively. Conflicts of interest may also arise if a person, or a member of his or her family, receives improper personal benefits as a result of his or her position.

 

Our audit committee, pursuant to its written charter, is responsible for reviewing and approving material or significant related-party transactions to the extent we enter into such transactions. The audit committee will consider all relevant factors when determining whether to approve a related party transaction, including whether the related party transaction is on terms no less favorable than terms generally available to an unaffiliated third-party under the same or similar circumstances and the extent of the related party’s interest in the transaction. No director may participate in the approval of any transaction in which he is a related party, but that director is required to provide the audit committee with all material information concerning the transaction. Additionally, we require each of our directors and executive officers to complete an annual directors’ and officers’ questionnaire that elicits information about related party transactions.

 

These procedures are intended to determine whether any such related party transaction impairs the independence of a director or presents a conflict of interest on the part of a director, employee or officer.

 

Employee, Officer, and Director Hedging Policy

 

We have adopted a policy regarding the ability of our employees, including officers, or directors (or any of their designees) to purchase financial instruments (including prepaid variable forward contracts, equity swaps, collars, and exchange funds), or otherwise engage in transactions, that “hedge” or offset, or are designed to hedge or offset, any decrease in the market value of our equity securities. Because such hedging transactions could permit a person to continue to own our securities without the full risks and rewards of ownership, and because when that occurs such person may no longer have the same objectives as our other shareholders, our policy prohibits our employees, officers, and directors from engaging in any such transactions.

 

21

 

 

DELINQUENT SECTION 16(a) REPORTS

 

Section 16(a) of the Exchange Act requires the Company’s directors, executive officers and persons who beneficially own 10% or more of a class of securities registered under Section 12 of the Exchange Act to file reports of beneficial ownership and changes in beneficial ownership with the SEC. Directors, executive officers and greater than 10% stockholders are required by the rules and regulations of the SEC to furnish the Company with copies of all reports filed by them in compliance with Section 16(a).

 

To the Company’s knowledge, based solely on a review of reports furnished to it and review of the Section 16 reports (Forms 3, 4 and 5 and any amendments to those forms) filed during (or with respect to) the fiscal year ended December 31, 2023, all of the Company’s officers, directors and ten percent holders have timely made the required filings.

 

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

The audit committee of our board of directors is directly responsible for the appointment, compensation, retention, and oversight of the independent registered public accounting firm that audits our financial statements and our internal control over financial reporting. The audit committee has selected PricewaterhouseCoopers Ltda. (“PwC”) as our independent registered public accounting firm for 2024. The audit committee annually reviews PwC’s independence and performance in deciding whether to retain PwC or engage a different independent registered public accounting firm.

 

   Year Ended December 31, 
   2023   2022 
Audit Fees(1)  $854,512   $692,754 
Audit-Related Fees(2)   -    376 
All Other Fees(3)   2,000    2,900 
Total Fees  $857,412   $696,030 

 

(1) Audit fees consist of fees paid for professional services by PwC for audit and quarterly review of the Company’s consolidated financial statements during the years ended December 31, 2023, and 2022, and related services normally provided in connection with statutory and regulatory filings or engagements.
   
(2) Audit-related fees represent the aggregate fees billed for assurance and related professional services rendered by PwC that are reasonably related to the performance of the audit or review of the Company’s financial statements and are not reported under “Audit Fees”.
   
(3) Other fees represent fees billed for professional services rendered by PwC in connection with subscription to information services and training. The Company was not billed for any fees billed in either of the last two fiscal years for professional services rendered by PwC for tax compliance, tax advice, and tax planning. Such “Tax Fees” would have been reported in the table above if any.

 

Pre-Approval Policies and Procedures. In accordance with Section 10A(i) of the Securities Exchange Act of 1934, as amended, before we engage our independent registered public accounting firm to render audit or non-audit services, the engagement is approved by our audit committee. Our audit committee approved all of the fees referred to in the rows titled “Audit Fees,” “Audit-Related Fees,” and “All Other Fees” in the table above.

 

Representatives of PwC are expected to attend the Annual General Meeting. The representatives will have an opportunity to make any statements and will be available to respond to appropriate questions from shareholders.

 

22

 

 

2025 ANNUAL GENERAL MEETING SHAREHOLDER PROPOSALS AND NOMINATIONS

 

In order for any shareholder proposal or nominations to be presented at the annual general meeting to be held in 2025 or to be eligible for inclusion in our proxy statement for such meeting, we must receive it at our principal executive offices by July 11, 2025. Each proposal should include the exact language of the proposal, a brief description of the matter and the reasons for the proposal, the name and address of the shareholder making the proposal and the disclosure of that shareholder’s number of ordinary shares owned, length of ownership of the shares, representation that the shareholder will continue to own the shares through the shareholder meeting, intention to appear in person or by proxy at the shareholder meeting and material interest, if any, in the matter being proposed.

 

Shareholders who wish to recommend to our nominating committee a candidate for election to our board of directors should send their letters to Tecnoglass Inc., 3550 NW 49th Street, Miami, Florida 33142, Attention: Nominating Committee. Shareholders must follow certain procedures to recommend to our nominating committee candidates for election as directors. In general, in order to provide sufficient time to enable our nominating committee to evaluate candidates recommended by shareholders in connection with selecting candidates for nomination in connection with our annual general meeting, we must receive the shareholder’s recommendation no later than thirty days after the end of our fiscal year.

 

The recommendation must contain the following information about the candidate:

 

  Name and age;
     
  Current business and residence addresses and telephone numbers, as well as residence addresses for the past 20 years;
     
  Principal occupation or employment and employment history (name and address of employer and job title) for the past 10 years (or such shorter period as the candidate has been in the workforce);
     
  Educational background;
     
  Permission for us to conduct a background investigation, including the right to obtain education, employment and credit information;
     
  The number of our ordinary shares beneficially owned by the candidate;
     
  The information that would be required to be disclosed by us about the candidate under the rules of the Securities and Exchange Commission in a proxy statement soliciting proxies for the election of such candidate as a director (which currently includes information required by Items 401, 404 and 405 of Regulation S-K promulgated by the Securities and Exchange Commission); and
     
  A signed consent of the nominee to serve as a director, if elected.

 

23

 

 

OTHER SHAREHOLDER COMMUNICATIONS WITH OUR BOARD OF DIRECTORS

 

Our board of directors provides a process for shareholders and interested parties to send communications to the board. Shareholders and interested parties may communicate with our board of directors, any committee chairperson or the non-management directors as a group by writing to the board or committee chairperson in care of Tecnoglass Inc., 3550 NW 49th Street, Miami, Florida 33142, Attention: Corporate Secretary. Each communication will be forwarded, depending on the subject matter, to the board of directors, the appropriate committee chairperson or all non-management directors. More information respecting communications with our board of directors may be found at investors.tecnoglass.com/contactboard.cfm.

 

DISCRETIONARY VOTING OF PROXIES

 

Pursuant to Rule 14a-4 promulgated by the Securities and Exchange Commission, shareholders are advised that our management will be permitted to exercise discretionary voting authority under proxies it solicits and obtains for our 2025 annual general meeting with respect to any proposal presented by a shareholder at such meeting, without any discussion of the proposal in our proxy statement for such meeting, unless we receive notice of such proposal at our principal office in Miami, Florida, not later than July 11, 2025.

 

OTHER MATTERS

 

Our board of directors knows of no matter that will be presented for consideration at the meeting other than the matters referred to in this proxy statement. Should any other matter properly come before the meeting, it is the intention of the persons named in the accompanying proxy to vote the proxy in accordance with their best judgment.

 

  By Order of the Board of Directors
   
  /s/ A. Lorne Weil, Chairman of the Board
   
Miami, Florida  
November 8, 2024  

 

24

 

 

TECNOGLASS INC.

Proxy

Solicited by the Board Of Directors

for Annual General Meeting to be held on December 3, 2024

 

The undersigned shareholder(s) of TECNOGLASS INC., a Cayman Islands exempted company (“Company”), hereby appoints Christian T. Daes and Santiago Giraldo, or any of them, with full power of substitution and to act without the others, as the agents, attorneys and proxies of the undersigned, to vote the shares standing in the name of the undersigned at the Company’s Annual General Meeting to be held on December 3, 2024 and at all adjournments thereof. This proxy will be voted in accordance with the instructions given below. If no instructions are given, this proxy will be voted FOR the election of Class B directors.

 

1. Election of the following Class B directors:

 

    A. Christian T. Daes FOR AGAINST ABSTAIN
                   
    B. Julio A. Torres FOR AGAINST ABSTAIN
                   

 

  Date: ___________________, 2024
   
   
  Signature
   
   
  Signature if held jointly
   
  Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.